Transpact Enter, a company in the Medical Equipment & Supplies industry, reported revenue of ₹0.09 crore and net profit of ₹0.04 crore for the March 2026 quarter.
Transpact Enter. (BSE: TRANSPACT) closed at ₹90.70 on 20 Nov 2026, down 45.0% over the past year. Its market capitalisation is ₹4 crore and it trades at 43.9 times earnings.
Incorporated in 2013, Transpact Enterprises Ltd deals in investment portfolio, Investment advisory, Corporate funding, Market consulting, for various clients
Descriptive research only, not investment advice. Evenstocks is not a SEBI-registered investment adviser.